Business

Vanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug

Published

on


Vanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version